Xinyu Guoke and PharmaBlock Sciences to List on SZSE

date: 2017-11-10

Xinyu Guoke (Stock Code: 300722) and PharmaBlock Sciences (Stock Code: 300725) will land on ChiNext board on November 10, 2017.

 

Xinyu Guoke is publicly offering 20 million shares, including 20 million IPO shares offered at 8.99 yuan per share and raising funds of 180 million yuan, and 0 share transferred by the existing shareholders at 0 yuan. The post-public-offering share capital of Xinyu Guoke is 80 million in total. Jiangxi Xinyu Guoke Technology Co., Ltd. is principally engaged in research and development, production and sales of military priming systems and related products. In 2016, its operating income reached 182 million yuan with the net profit of 34.2345 million yuan.

 

PharmaBlock Sciences is publicly offering 18.3333 million shares, including 18.3333 million IPO shares offered at 11.32 yuan per share and raising funds of 208 million yuan, and 0 share transferred by the existing shareholders at 0 yuan. The post-public-offering share capital of PharmaBlock Sciences is 73.3333 million in total. PharmaBlock Sciences (Nanjing), Inc. is principally engaged in design, synthesis and sale of drug molecular blocks; technique development, pilot test, commercial production and sale of key intermediates; and provision of relevant technical services on research and development, techniques and production of drug molecular blocks. In 2016, its operating income reached 188 million yuan with the net profit of 36.1152 million yuan.